BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15089805)

  • 1. Drug metabolism and ageing.
    Kinirons MT; O'Mahony MS
    Br J Clin Pharmacol; 2004 May; 57(5):540-4. PubMed ID: 15089805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related changes in pharmacokinetics.
    Shi S; Klotz U
    Curr Drug Metab; 2011 Sep; 12(7):601-10. PubMed ID: 21495970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of drug metabolism in aging.
    McClay JL
    Aging (Albany NY); 2021 Jul; 13(13):16898-16899. PubMed ID: 34251355
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug metabolism by the cytochrome p-450 enzyme. Variability of polymorphisms and exogenous carriers].
    Kreutzkamp B
    Med Monatsschr Pharm; 2006 Feb; 29(2):48-50. PubMed ID: 16506587
    [No Abstract]   [Full Text] [Related]  

  • 5. A basic conceptual and practical overview of interactions with highly prescribed drugs.
    Dresser GK; Bailey DG
    Can J Clin Pharmacol; 2002; 9(4):191-8. PubMed ID: 12584577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ageing on cytochrome p450 enzymes: consequences for drug biotransformation in the elderly.
    Wauthier V; Verbeeck RK; Calderon PB
    Curr Med Chem; 2007; 14(7):745-57. PubMed ID: 17346160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [50 years of cytochrome P450. Drug metabolism - from past to present].
    Saussele T
    Med Monatsschr Pharm; 2014 Aug; 37(8):295-8. PubMed ID: 25158378
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism.
    Shephard EA; Phillips IR
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1083-94. PubMed ID: 20629583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450s: mechanisms and biological implications in drug metabolism and its interaction with oxidative stress.
    Bhattacharyya S; Sinha K; Sil PC
    Curr Drug Metab; 2014; 15(7):719-42. PubMed ID: 25429675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of drug metabolizing enzymes in the effect and side-effect of the drugs].
    Vereczkey L; Jemnitz K; Monostory K; Veres Z; Kóbori L
    Orv Hetil; 2005 May; 146(19):947-52. PubMed ID: 15969306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolism of drugs. III. Genetic factors inducing and inhibiting metabolism].
    Dyderski S; Grzymisławski M
    Pol Merkur Lekarski; 2005 Apr; 18(106):457-61. PubMed ID: 16161934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
    Schroer K; Kittelmann M; Lütz S
    Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytochrome p450 and their implication in chemotherapy].
    Delwaide PA
    Rev Med Liege; 1998 Nov; 53(11):700-10. PubMed ID: 9887664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic drug metabolizing CYP-enzymes--a pathogenic factor in oral lichen planus?
    Kragelund C; Hansen C; Reibel J; Nauntofte B; Broesen K; Pedersen AM; Smidt D; Eiberg H; Torpet LA
    J Oral Pathol Med; 2009 Jan; 38(1):63-71. PubMed ID: 19192051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of CKD on Cytochrome P450-Mediated Drug Metabolism.
    Ladda MA; Goralski KB
    Adv Chronic Kidney Dis; 2016 Mar; 23(2):67-75. PubMed ID: 26979145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions.
    Kumar YS; Adukondalu D; Sathish D; Vishnu YV; Ramesh G; Latha AB; Reddy PC; Sarangapani M; Rao YM
    Drug Metabol Drug Interact; 2010; 25(1-4):3-16. PubMed ID: 21417789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
    Oscarson M
    Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug essentials. The cytochrome P450 microenzyme system and targeted therapies: Minimizing drug interactions.
    Wilkes GM
    Oncology (Williston Park); 2009 Feb; 23(2 Suppl Nurse Ed):33, 52-6. PubMed ID: 19856586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.